State Ledger
Company profile

Veradermics, Inc CIK 1827635

Ticker
MANE (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
New Haven, CT 06513
Fiscal year end
2025 (FY)
Market Data
Close
$130.63
Change
+$4.55
Change %
3.61%
Volume
92,929

MANE · trading date Oct 9, 2026 · previous close $126.08 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$70.00M
Total assets
$152.62M
Total liabilities
$9.16M
Stockholders' equity
-$121.01M
Cash & equivalents
$21.77M
Operating income
-$72.35M
Operating cash flow
-$71.60M
Capital expenditures
$24.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$71.63M
Free cash flow margin
—
Liabilities / assets
6.0%
Equity / assets
-79.3%
CapEx / revenue
—
Operating cash flow / net income
1.02×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$70.00M $152.62M $9.16M -$121.01M
2024 — -$26.49M $55.54M $4.72M -$48.48M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-03
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New Haven, CT 06513
470 JAMES STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Connecticut — Public Companies